Henan Lingrui Pharmaceutical Co., Ltd. (SHA:600285)
China
· Delayed Price · Currency is CNY 21.48
+0.29 (1.37%)
Mar 10, 2026, 11:29 AM CST
SHA:600285 Revenue
Henan Lingrui Pharmaceutical had revenue of 942.16M CNY in the quarter ending September 30, 2025, with 10.44% growth. This brings the company's revenue in the last twelve months to 3.78B, up 6.15% year-over-year. In the year 2024, Henan Lingrui Pharmaceutical had annual revenue of 3.50B with 5.72% growth.
Revenue (ttm)
3.78B
Revenue Growth
+6.15%
P/S Ratio
3.15
Revenue / Employee
1.55M
Employees
2,435
Market Cap
11.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.50B | 189.36M | 5.72% |
| Dec 31, 2023 | 3.31B | 309.61M | 10.31% |
| Dec 31, 2022 | 3.00B | 308.35M | 11.45% |
| Dec 31, 2021 | 2.69B | 361.93M | 15.52% |
| Dec 31, 2020 | 2.33B | 174.53M | 8.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisun Pharmaceutical | 9.84B |
| Zhejiang Hisoar Pharmaceutical | 1.86B |
| Guangdong Taienkang Pharmaceutical | 674.49M |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Porton Pharma Solutions | 3.43B |
| Mayinglong Pharmaceutical Group | 3.77B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Zhejiang CONBA Pharmaceutical | 6.58B |